Články s príkazom na verejný prístup - Maria Teresa Di MartinoĎalšie informácie
Nedostupné nikde: 4
Mir-221/222 are promising targets for innovative anticancer therapy
MT Di Martino, M Rossi, D Caracciolo, A Gullà, P Tagliaferri, P Tassone
Expert Opinion on Therapeutic Targets 20 (9), 1099-1108, 2016
Príkazy: US National Institutes of Health
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma
M Rossi, E Altomare, C Botta, ME Gallo Cantafio, S Sarvide, D Caracciolo, ...
Leukemia 35 (3), 823-834, 2021
Príkazy: AIRC Foundation for Cancer Research in Italy
Error‐prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment
D Caracciolo, C Riillo, M Arbitrio, MT Di Martino, P Tagliaferri, P Tassone
International journal of cancer 147 (10), 2658-2668, 2020
Príkazy: AIRC Foundation for Cancer Research in Italy
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS
S Franzoni, L Morbioli, A Turtoro, L Solazzo, A Greco, M Arbitrio, ...
Journal of Pharmaceutical and Biomedical Analysis 188, 113451, 2020
Príkazy: AIRC Foundation for Cancer Research in Italy
Dostupné niekde: 38
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
Príkazy: US National Institutes of Health
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
E Leone, E Morelli, MT Di Martino, N Amodio, U Foresta, A Gullà, M Rossi, ...
Clinical Cancer Research 19 (8), 2096-2106, 2013
Príkazy: US National Institutes of Health
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic “dark matter”
K Grillone, C Riillo, F Scionti, R Rocca, G Tradigo, PH Guzzi, S Alcaro, ...
Journal of Experimental & Clinical Cancer Research 39, 1-19, 2020
Príkazy: AIRC Foundation for Cancer Research in Italy
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
Príkazy: US National Institutes of Health
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
D Cosco, F Cilurzo, J Maiuolo, C Federico, MT Di Martino, MC Cristiano, ...
Scientific reports 5 (1), 17579, 2015
Príkazy: Government of Italy
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
MT Di Martino, V Campani, G Misso, ME Gallo Cantafio, A Gulla, ...
PloS one 9 (2), e90005, 2014
Príkazy: Government of Italy
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
E Morelli, E Leone, ME Cantafio, MT Di Martino, N Amodio, L Biamonte, ...
Leukemia 29 (11), 2173-2183, 2015
Príkazy: US National Institutes of Health, US Department of Veterans Affairs
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T Calimeri, E Battista, F Conforti, P Neri, MT Di Martino, M Rossi, ...
Leukemia 25 (4), 707-711, 2011
Príkazy: US National Institutes of Health
A 13 mer LNA-i-miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells
A Gullà, MT Di Martino, ME Gallo Cantafio, E Morelli, N Amodio, C Botta, ...
Clinical cancer research 22 (5), 1222-1233, 2016
Príkazy: US National Institutes of Health, US Department of Veterans Affairs
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review
MT Di Martino, M Arbitrio, D Caracciolo, A Cordua, O Cuomo, K Grillone, ...
Molecular Therapy-Nucleic Acids 27, 1191-1224, 2022
Príkazy: AIRC Foundation for Cancer Research in Italy
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
DC Rigiracciolo, MF Santolla, R Lappano, A Vivacqua, F Cirillo, GR Galli, ...
Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019
Príkazy: AIRC Foundation for Cancer Research in Italy
miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy
MT Di Martino, C Riillo, F Scionti, K Grillone, N Polerà, D Caracciolo, ...
Cancers 13 (7), 1587, 2021
Príkazy: AIRC Foundation for Cancer Research in Italy
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92
E Morelli, L Biamonte, C Federico, N Amodio, MT Di Martino, ...
Blood, The Journal of the American Society of Hematology 132 (10), 1050-1063, 2018
Príkazy: US National Institutes of Health
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
C Botta, M Cucè, MR Pitari, D Caracciolo, A Gulla, E Morelli, C Riillo, ...
Leukemia 32 (4), 1003-1015, 2018
Príkazy: US National Institutes of Health
Transferrin‐conjugated SNALPs encapsulating 2′‐O‐methylated miR‐34a for the treatment of multiple myeloma
I Scognamiglio, MT Di Martino, V Campani, A Virgilio, A Galeone, A Gullà, ...
BioMed research international 2014 (1), 217365, 2014
Príkazy: Government of Italy
Alternative non-homologous end-joining: error-prone DNA repair as cancer’s achilles’ heel
D Caracciolo, C Riillo, MT Di Martino, P Tagliaferri, P Tassone
Cancers 13 (6), 1392, 2021
Príkazy: AIRC Foundation for Cancer Research in Italy
Informácie o zverejnení a financovaní sú automaticky vyberané počítačovým programom